Evidence map›Paper›PMID 35805784›Full record

ArticleInternational journal of environmental research and public health2022

The HIV Epidemic in South Africa: Key Findings from 2017 National Population-Based Survey.

Khangelani Zuma, Leickness Simbayi, Nompumelelo Zungu, Sizulu Moyo, Edmore Marinda, Sean Jooste, Alicia North, Patrick Nadol, Getahun Aynalem, Ehimario Igumbor and 8 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Tuberculosis in Pregnancy: Challenges of Immune Protection.The Journal of infectious diseases · 2026
    Review
  12. Article
  13. Effects of HIV and Adverse Childhood Experiences on Neurocognition.Journal of acquired immune deficiency syndromes (1999) · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Khangelani ZumaHuman Sciences Research Council, Pretoria 0001, South Africa.
Leickness SimbayiHuman Sciences Research Council, Cape Town 8000, South Africa.
Nompumelelo ZunguHuman Sciences Research Council, Pretoria 0001, South Africa.
Sizulu MoyoHuman Sciences Research Council, Cape Town 8000, South Africa.
Edmore MarindaHuman Sciences Research Council, Pretoria 0001, South Africa.
Sean JoosteHuman Sciences Research Council, Cape Town 8000, South Africa.
Alicia NorthHuman Sciences Research Council, Cape Town 8000, South Africa.
Patrick NadolDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Pretoria 0001, South Africa.
Getahun AynalemDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Pretoria 0001, South Africa.
Ehimario IgumborDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Pretoria 0001, South Africa.
Cheryl DietrichDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Pretoria 0001, South Africa.
Salome SigidaHuman Sciences Research Council, Pretoria 0001, South Africa.
Buyisile ChibiHuman Sciences Research Council, Pretoria 0001, South Africa.
Lehlogonolo MakolaHuman Sciences Research Council, Cape Town 8000, South Africa.
Lwando KondloHuman Sciences Research Council, Pretoria 0001, South Africa.
Sarah PorterDivision of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Pretoria 0001, South Africa.
Shandir RamlaganHuman Sciences Research Council, Pretoria 0001, South Africa.
On Behalf Of The Sabssm V Study Group Contributors

Funding

PEPFAR NU2GGH001629
6 · The paper itself

Abstract

South Africa has the largest number of people living with HIV worldwide. South Africa has implemented five population-based HIV prevalence surveys since 2002 aimed at understanding the dynamics and the trends of the epidemic. This paper presents key findings from the fifth HIV prevalence, incidence, and behaviour survey conducted in 2017 following policy, programme, and epidemic change since the prior survey was conducted in 2012. A cross-sectional population-based household survey collected behavioural and biomedical data on all members of the eligible households. A total of 39,132 respondents from 11,776 households were eligible to participate, of whom 93.6% agreed to be interviewed, and 61.1% provided blood specimens. The provided blood specimens were used to determine HIV status, HIV incidence, viral load, exposure to antiretroviral treatment, and HIV drug resistance. Overall HIV incidence among persons aged 2 years and above was 0.48% which translates to an estimated 231,000 new infections in 2017. HIV prevalence was 14.0% translating to 7.9 million people living with HIV. Antiretroviral (ARV) exposure was 62.3%, with the lowest exposure among those aged 15 to 24 years (39.9%) with 10% lower ARV coverage among males compared to females. Viral suppression among those on treatment was high (87.3%), whilst HIV population viral load suppression was much lower (62.3%). In terms of risk behaviours, 13.6% of youth reported having had an early sexual debut (first sex before the age of 15 years), with more males reporting having done so (19.5%) than females (7.6%). Age-disparate relationships, defined as having a sexual partner 5+ years different from oneself,) among adolescents were more common among females (35.8%) than males (1.5%). Self-reported multiple sexual partnerships (MSPs), defined as having more than one sexual partner in the previous 12 months, were more commonly reported by males (25.5%) than females (9.0%). Condom use at last sexual encounter was highest among males than females. Three quarters (75.2%) of people reported they had ever been tested for HIV, with more females (79.3%) having had done so than males (70.9%). Two-thirds of respondents (66.8%) self-reported having tested for HIV in the past 12 months. Finally, 61.6% of males in the survey self-reported as having been circumcised, with circumcision being more common among youth aged 15-24 years (70.2%), Black Africans (68.9%), and those living in both rural informal (tribal) areas (65%) and urban areas (61.9%). Slightly more (51.2%) male circumcisions were reported to have occurred in a medical setting than in traditional settings (44.8%), with more young males aged 15-24 (62.6%) and men aged 25-49 (51.5%) reporting to have done so compared to most men aged 50 and older (57.1%) who reported that they had undergone circumcision in a traditional setting. The results of this survey show that strides have been made in controlling the HIV epidemic, especially in the reduction of HIV incidence, HIV testing, and treatment. Although condom use at last sex act remains unchanged, there continue to be some challenges with the lack of significant behaviour change as people, especially youth, continue to engage in risky behaviour and delay treatment initiation. Therefore, there is a need to develop or scale up targeted intervention programmes to increase HIV testing further and put more people living with HIV on treatment as well as prevent risky behaviours that put young people at risk of HIV infection.

Indexed as

HIV InfectionsAdolescentAgedAnti-Retroviral AgentsCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceSexual BehaviorSouth AfricaAnti-Retroviral AgentsAntiretroviral (ARV) exposureHIV incidenceHIV prevalenceHIV testingpopulation-based surveyrisk behaviourSouth Africaviral load suppression

Identifiers

PMID35805784
PMCPMC9265818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.